Organizer Description: This recent webinar provides the most recent update on the autologous cell therapy for Parkinson’s disease’s (PD) progress and its clinical trial progress. Summit for Stem Cell Foundation supported the autologous cell therapy for PD in its earlier stages as a research project (Autologous Cell-based therapy for Parkinson’s disease) until, as a part of the team, helped found Aspen Neuroscience.

In Spring 2024, the autologous cell therapy for PD received FDA IND clearance and Fast Track Designation and Phase 1/2a for ANPD001 and is now completed!